Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program
Authors:
- Jan ÖstergrenJÖJan Östergren
- Inder AnandIAInder Anand
- Margareta PuuMPMargareta Puu
- Scott D. SolomonSSScott D. Solomon
- Eric L. MichelsonEMEric L. Michelson
- Bertil OlofssonBOBertil Olofsson
- Christopher B. GrangerCGChristopher B. Granger
- Salim YusufSYSalim Yusuf
- Karl SwedbergKSKarl Swedberg
- Marc A. PfefferMPMarc A. Pfeffer
- John J.V. McMurrayJMJohn J.V. McMurray
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansEuropean Heart Journal, 2008
- Blood Pressure in Heart Failure: A Love-Hate RelationshipJACC, 2007
- Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure TrialJACC, 2007
- The association between blood pressure and mortality in patients with heart failureAmerican Heart Journal, 2006
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the AdultJACC, 2005
- Public awareness of heart failure in Europe: first results from SHAPEEuropean Heart Journal, 2005
- Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic DysfunctionCirculation, 2004
- Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failureJACC, 2004
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Tolerability of enalapril initiation by patients with left ventricular dysfunction: Results of the medication challenge phase of the studies of left ventricular dysfunctionAmerican Heart Journal, 1994